Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis
Journal of Inflammation Research · 2026-08 · Volume 19 · 1-14
DOI: 10.2147/jir.s546264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-08. Verfasst von Morgan Fairweather und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
- Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, 20132, Italy.
- Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
ORCID-Profile: Ilaria Faggiani, Christopher Ma
Zitieren
APA
Fairweather, M., Faggiani, I., & Ma, C. (2026). Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis. Journal of Inflammation Research, Volume 19, 1-14. https://doi.org/10.2147/jir.s546264
Vancouver
Fairweather M, Faggiani I, Ma C. Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis. Journal of Inflammation Research. 2026;Volume 19:1-14. doi:10.2147/jir.s546264
BibTeX
@article{Fairweather2026,
author = {Fairweather, Morgan and Faggiani, Ilaria and Ma, Christopher},
title = {Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jir.s546264}
}
EUVIMED